Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 09:31 am Purchase |
2024-09-30 | 13G | Ascendis Pharma A/S ASND |
Avoro Capital Advisors LLC | 4,988,888 8.200% |
1,233,333 (+32.84%) |
Filing History |
| 2024-11-14 09:30 am Purchase |
2024-09-30 | 13G | Kymera Therapeutics, Inc. KYMR |
Avoro Capital Advisors LLC | 7,750,000 9.990% |
3,975,000 (+105.30%) |
Filing History |
| 2024-04-23 6:22 pm Sale |
2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE |
Avoro Capital Advisors LLC | 1,839,138 5.100% |
-286,459 (-13.48%) |
Filing History |
| 2024-02-14 09:25 am Purchase |
2023-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Avoro Capital Advisors LLC | 2,565,555 9.100% |
1,155,555 (+81.95%) |
Filing History |
| 2024-02-14 09:23 am Purchase |
2023-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
Avoro Capital Advisors LLC | 13,411,111 9.900% |
2,786,111 (+26.22%) |
Filing History |
| 2024-02-14 09:22 am Purchase |
2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Avoro Capital Advisors LLC | 27,400,000 9.300% |
600,000 (+2.24%) |
Filing History |
| 2024-02-14 09:21 am Purchase |
2023-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
Avoro Capital Advisors LLC | 2,288,888 9.900% |
628,888 (+37.88%) |
Filing History |
| 2024-02-14 09:20 am Sale |
2023-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
Avoro Capital Advisors LLC | 0 0.000% |
-7,550,000 (Position Closed) |
Filing History |
| 2024-02-14 09:18 am Sale |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Avoro Capital Advisors LLC | 0 0.000% |
-3,060,000 (Position Closed) |
Filing History |
| 2024-02-14 09:17 am Purchase |
2023-12-31 | 13G | Ascendis Pharma A/S ASND |
Avoro Capital Advisors LLC | 3,755,555 6.500% |
655,555 (+21.15%) |
Filing History |
| 2024-02-14 09:15 am Sale |
2023-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
Avoro Capital Advisors LLC | 3,775,000 6.800% |
-75,000 (-1.95%) |
Filing History |
| 2024-02-14 09:14 am Purchase |
2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
Avoro Capital Advisors LLC | 4,535,000 9.100% |
210,000 (+4.86%) |
Filing History |
| 2024-02-14 09:13 am Sale |
2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
Avoro Capital Advisors LLC | 4,886,840 7.000% |
-668,715 (-12.04%) |
Filing History |
| 2024-02-14 09:12 am Purchase |
2023-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
Avoro Capital Advisors LLC | 5,666,666 7.700% |
766,666 (+15.65%) |
Filing History |
| 2024-02-14 09:10 am Purchase |
2023-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
Avoro Capital Advisors LLC | 6,583,332 9.990% |
6,583,332 (New Position) |
Filing History |
| 2024-02-14 09:09 am Purchase |
2023-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
Avoro Capital Advisors LLC | 16,337,739 9.990% |
3,537,739 (+27.64%) |
Filing History |
| 2024-02-14 09:08 am Purchase |
2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE |
Avoro Capital Advisors LLC | 2,125,597 5.900% |
2,125,597 (New Position) |
Filing History |
| 2024-02-14 09:07 am Purchase |
2023-12-31 | 13G | Structure Therapeutics Inc. GPCR |
Avoro Capital Advisors LLC | 6,999,999 5.000% |
6,999,999 (New Position) |
Filing History |
| 2024-02-14 09:05 am Sale |
2023-12-31 | 13G | United Therapeutics Corporation UTHR |
Avoro Capital Advisors LLC | 2,858,888 6.100% |
-6,112 (-0.21%) |
Filing History |
| 2024-02-14 09:04 am Unchanged |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Avoro Capital Advisors LLC | 3,150,000 5.800% |
0 (Unchanged) |
Filing History |